{
    "symbol": "AYTU",
    "quarter": 1,
    "year": 2022,
    "date": "2021-11-15 21:31:10",
    "content": " Our borrowing on the revolver at the end of September was only core $4.5 million versus $7.9 million at June 30th, 2021.That revenue for the fiscal quarter ended September 30th, 2021 was $21.9 million, compared to $13.5 million in the same quarter in 2020, a year-over-year increase of 62%. Net revenue from the consumer health division for the 3 months ended September 30th, 2021 was $8 million compared to $7.8 million in the same quarter last year. Net revenue for the prescription division for the 3 months ended September 30, 2021 was $13.9 million up from $5.8 million in the same quarter last year. For the first fiscal quarter of 2022, Net loss was $27.9 million or a $1.9 per share as compared to $4.3 million for $0.35 per share, for the same period last year."
}